BASKING RIDGE, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, announces that management will present a company overview and hold virtual investor meetings at the H.C. Wainwright Global Life Sciences Virtual Conference being held March 9-10, 2021.

Here is the original post:
Caladrius Biosciences to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh